Kaymaz-Tahra, S. Et Al. 2024. Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms. ACR Convergence 2024 , (Washington, Kiribati).

Kaymaz-Tahra, S., BAYINDIR TSECHELIDIS, Ö., İNCE, B., ÖZDEMİR IŞIK, Ö., TUNCER KURU, F., KARAKAŞ, Ö., ... DEMİRCİ YILDIRIM, T.(2024). Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms . ACR Convergence 2024, Washington, Kiribati

Kaymaz-Tahra, Sema Et Al. "Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms," ACR Convergence 2024, Washington, Kiribati, 2024

Kaymaz-Tahra, Sema Et Al. "Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms." ACR Convergence 2024 , Washington, Kiribati, 2024

Kaymaz-Tahra, S. Et Al. (2024) . "Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms." ACR Convergence 2024 , Washington, Kiribati.

@conferencepaper{conferencepaper, author={Sema Kaymaz-Tahra Et Al. }, title={Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms}, congress name={ACR Convergence 2024}, city={Washington}, country={Kiribati}, year={2024}}